The FDA's promo police slap four more pharmas in year-end enforcement spree

The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. Since the beginning of the month, the Office of Prescription Drug Promotion has cited six drugmakers for overstepping their bounds, more than half of its enforcement actions this year.